Effects of Empagliflozin on vascular and skeletal mineralization in Hyperlipidemic mice

By sjmartinez • May 2, 2024

Kalanski S, Pradhan S, Hon A, Xia Y, Safvati N, Rivera JC, Lu M, Demer LL, Tintut Y. Effects of Empagliflozin on vascular and skeletal mineralization in Hyperlipidemic mice. Vascul Pharmacol. 2024 Apr 29:107376. doi: 10.1016/j.vph.2024.107376. Epub ahead of print. PMID: 38692418.

Tags: Cardiology/Epi, empagliflozin, hyperlipidemia, Publications, SGLT2

Associations of cigarette smoking with coronary artery and extra-coronary calcification in older adults: The Atherosclerosis Risk in Communities study

Chen M, Ding N, Wang FM, Obisesan OH, Folsom AR, Howard-Claudio CM, Budoff M, Blaha MJ, Matsushita K. Associations of cigarette smoking with coronary artery[...]

HFpEF and MASLD: converging mechanisms and clinical implications

Capone F, Häseli SP, Liu L, Strocchi S, Langenberg C, Lusis AJ, Pietzner M, Muoio DM, Rider OJ, Raman B, Fudim M, Romeo S, Wang[...]

James S. Lee, MD Appointed Community Clinical Chief of Cardiology

We are pleased to announce the appointment of James S. Lee, MD as the new community clinical chief of cardiology in the UCLA Department of Medicine Division[...]